GATA-1 utilizes ikaros and polycomb repressive complex 2 to suppress HES1 and to promote erythropoiesis

Molecular and Cellular Biology

Volumn 32, Issue 18, 2012, Pages 3624-3638

  Ross, Julie ^a   Mavoungou, Lionel ^a   Bresnick, Emery H ^b   Milot, Eric ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE MI 2; ALPHA ACTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE LYSINE METHYLTRANSFERASE; IKAROS TRANSCRIPTION FACTOR; NOTCH RECEPTOR; POLYCOMB GROUP PROTEIN; POLYCOMB REPRESSIVE COMPLEX 2; PROTEIN FOG 1; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GFI1B; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CHROMATIN; CONTROLLED STUDY; ERYTHROBLAST; ERYTHROID CELL; ERYTHROPOIESIS; FETUS; GENE; GENE EXPRESSION; GENE REPRESSION; HEMATOPOIESIS; HES1 GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL LINE; CERCOPITHECUS AETHIOPS; CHROMATIN; COS CELLS; ERYTHROPOIESIS; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HISTONES; HOMEODOMAIN PROTEINS; IKAROS TRANSCRIPTION FACTOR; MI-2 NUCLEOSOME REMODELING AND DEACETYLASE COMPLEX; MICE; NUCLEAR PROTEINS; POLYCOMB REPRESSIVE COMPLEX 2; POLYCOMB-GROUP PROTEINS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

MUS;

EID: 84866359488     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00163-12     Document Type: Article

References (65)

1. Adamo A, Barrero MJ, Belmonte JC. 2011. LSD1 and pluripotency: a new player in the network. Cell Cycle 10:3215-3216.
2. Alcalay M, et al. 2003. Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair. J. Clin. Invest. 112:1751-1761.
3. Bank A. 2006. Regulation of human fetal hemoglobin: new players, new complexities. Blood 107:435-443.
4. Bigas A, Robert-Moreno A, Espinosa L. 2010. The Notch pathway in the developing hematopoietic system. Int. J. Dev. Biol. 54:1175-1188.
5. Bottardi S, et al. 2009. Ikaros and GATA-1 combinatorial effect is required for silencing of human gamma-globin genes. Mol. Cell. Biol. 29: 1526-1537.
6. Bottardi S, Ross J, Pierre-Charles N, Blank V, Milot E. 2006. Lineagespecific activators affect beta-globin locus chromatin in multipotent hematopoietic progenitors. EMBO J. 25:3586-3595.
7. Bottardi S, et al. 2011. Ikaros interacts with P-TEFb and cooperates with GATA-1 to enhance transcription elongation. Nucleic Acids Res. 39: 3505-3519.
8. Bray SJ. 2006. Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 7:678-689.
9. Chari S, Umetsu SE, Winandy S. 2010. Notch target gene deregulation and maintenance of the leukemogenic phenotype do not require RBP-J. kappa in Ikaros null mice. J. Immunol. 185:410-417.
10. Chari S, Winandy S. 2008. Ikaros regulates Notch target gene expression in developing thymocytes. J. Immunol. 181:6265-6274.
11. Cheng Y, et al. 2009. Erythroid GATA1 function revealed by genomewide analysis of transcription factor occupancy, histone modifications, and mRNA expression. Genome Res. 19:2172-2184.
12. Dumortier A, et al. 2006. Notch activation is an early and critical event during T-cell leukemogenesis in Ikaros-deficient mice. Mol. Cell. Biol. 26:209-220.
13. Elagib KE, et al. 2004. Jun blockade of erythropoiesis: role for repression of GATA-1 by HERP2. Mol. Cell. Biol. 24:7779-7794.
14. Fischer A, Gessler M. 2007. Delta-Notch-and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors. Nucleic Acids Res. 35:4583-4596.
15. Fraser PJ, Curtis PJ. 1987. Specific pattern of gene expression during induction of mouse erythroleukemia cells. Genes Dev. 1:855-861.
16. Fujiwara T, et al. 2009. Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol. Cell 36:667-681.
17. Fujiwara Y, Browne CP, Cunniff K, Goff SC, Orkin SH. 1996. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl. Acad. Sci. U. S. A. 93:12355-12358.
18. Georgopoulos K. 2002. Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat. Rev. Immunol. 2:162-174.
19. Gomez-del Arco P, et al. 2010. Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis. Immunity 33:685-698.
20. Hadland BK, et al. 2004. A requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development. Blood 104:3097-3105.
21. Henning K, et al. 2007. mNotch1 signaling and erythropoietin cooperate in erythroid differentiation of multipotent progenitor cells and upregulate beta-globin. Exp. Hematol. 35:1321-1332.
22. Hong W, et al. 2005. FOG-1 recruits the NuRD repressor complex to mediate transcriptional repression by GATA-1. EMBO J. 24:2367-2378.
23. Ishiko E, et al. 2005. Notch signals inhibit the development of erythroid/ megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1. J. Biol. Chem. 280:4929-4939.
24. Jimenez G, Griffiths SD, Ford AM, Greaves MF, Enver T. 1992. Activation of the beta-globin locus control region precedes commitment to the erythroid lineage. Proc. Natl. Acad. Sci. U. S. A. 89:10618-10622.
25. Kawamata S, Du C, Li K, Lavau C. 2002. Overexpression of the Notch target genes Hes in vivo induces lymphoid and myeloid alterations. Oncogene 21:3855-3863.
26. Kim SI, Bultman SJ, Jing H, Blobel GA, Bresnick EH. 2007. Dissecting molecular steps in chromatin domain activation during hematopoietic differentiation. Mol. Cell. Biol. 27:4551-4565.
27. Klinakis A, et al. 2011. A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature 473:230-233.
28. Koipally J, Renold A, Kim J, Georgopoulos K. 1999. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J. 18:3090-3100.
29. Lam LT, Ronchini C, Norton J, Capobianco AJ, Bresnick EH. 2000. Suppression of erythroid but not megakaryocytic differentiation of human K562 erythroleukemic cells by notch-1. J. Biol. Chem. 275:19676-19684.
30. Lin TS, Ishiguro K, Sartorelli AC. 1998. Role of gp55 in restoring the sensitivity of Friend murine erythroleukemia cells to erythropoietin by exposure to dimethyl sulfoxide. Oncol. Res. 10:175-184.
31. Makishima H, et al. 2010. Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Leukemia 24:1799-1804.
32. Miccio A, et al. 2010. NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development. EMBO J. 29:442-456.
33. Mukherjee T, Kim WS, Mandal L, Banerjee U. 2011. Interaction between Notch and Hif-alpha in development and survival of Drosophila blood cells. Science 332:1210-1213.
34. Muller P, et al. 2010. SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells. Breast Cancer Res. Treat. 120:317-326.
35. Mullighan C, Downing J. 2008. Ikaros and acute leukemia. Leuk. Lymphoma 49:847-849.
36. Muntean AG, Ge Y, Taub JW, Crispino JD. 2006. Transcription factor GATA-1 and Down syndrome leukemogenesis. Leuk. Lymphoma 47: 986-997.
37. Nakahara F, et al. 2010. Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia. Blood 115:2872-2881.
38. Nichogiannopoulou A, Trevisan M, Neben S, Friedrich C, Georgopoulos K. 1999. Defects in hemopoietic stem cell activity in Ikaros mutant mice. J. Exp. Med. 190:1201-1214.
39. Nudel U, et al. 1977. Accumulation of alpha- and beta-globin messenger RNAs in mouse erythroleukemia cells. Cell 12:463-469.
40. Palis J, Yoder MC. 2001. Yolk-sac hematopoiesis: the first blood cells of mouse and man. Exp. Hematol. 29:927-936.
41. Pevny L, et al. 1995. Development of hematopoietic cells lacking transcription factor GATA-1. Development 121:163-172.
42. Pevny L, et al. 1991. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349:257-260.
43. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45.
44. Pilon AM, et al. 2011. Genome-wide ChIP-Seq reveals a dramatic shift in the binding of the transcription factor erythroid Kruppel-like factor during erythrocyte differentiation. Blood 118:e139-148.
45. Pulte D, et al. 2006. Ikaros increases normal apoptosis in adult erythroid cells. Am. J. Hematol. 81:12-18.
46. Robert-Moreno A, Espinosa L, Sanchez MJ, de la Pompa JL, Bigas A. 2007. The notch pathway positively regulates programmed cell death during erythroid differentiation. Leukemia 21:1496-1503.
47. Rodriguez P, et al. 2005. GATA-1 forms distinct activating and repressive complexes in erythroid cells. EMBO J. 24:2354-2366.
48. Saleque S, Kim J, Rooke HM, Orkin SH. 2007. Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol. Cell 27:562-572.
49. Sang L, Roberts JM, Coller HA. 2010. Hijacking HES1: how tumors co-opt the anti-differentiation strategies of quiescent cells. Trends Mol. Med. 16:17-26.
50. Shelly LL, Fuchs C, Miele L. 1999. Notch-1 inhibits apoptosis in murine erythroleukemia cells and is necessary for differentiation induced by hybrid polar compounds. J. Cell Biochem. 73:164-175.
51. Simon MC, et al. 1992. Rescue of erythroid development in gene targeted GATA-1- mouse embryonic stem cells. Nat. Genet. 1:92-98.
52. Singer D, Cooper M, Maniatis GM, Marks PA, Rifkind RA. 1974. Erythropoietic differentiation in colonies of cells transformed by Friend virus. Proc. Natl. Acad. Sci. U. S. A. 71:2668-2670.
53. Socolovsky M, et al. 2007. Negative autoregulation by FAS mediates robust fetal erythropoiesis. PLoS Biol. 5:e252. doi:10.1371/journal.pbio.0050252.
54. Soler E, et al. 2010. The genome-wide dynamics of the binding of Ldb1 complexes during erythroid differentiation. Genes Dev. 24:277-289.
55. Takahashi S, et al. 1997. Arrest in primitive erythroid cell development caused by promoter-specific disruption of the GATA-1 gene. J. Biol. Chem. 272:12611-12615.
56. Tsai SF, Strauss E, Orkin SH. 1991. Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter. Genes Dev. 5:919-931.
57. Tsiftsoglou AS, Vizirianakis IS, Strouboulis J. 2009. Erythropoiesis: model systems, molecular regulators, and developmental programs. IUBMB Life 61:800-830.
58. Wang JH, et al. 1996. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5:537-549.
59. Weiss MJ, Orkin SH. 1995. Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc. Natl. Acad. Sci. U. S. A. 92:9623-9627.
60. Weiss MJ, Yu C, Orkin SH. 1997. Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a genetargeted cell line. Mol. Cell. Biol. 17:1642-1651.
61. Welch JJ, et al. 2004. Global regulation of erythroid gene expression by transcription factor GATA-1. Blood 104:3136-3147.
62. Whyatt D, et al. 2000. An intrinsic but cell-nonautonomous defect in GATA-1-overexpressing mouse erythroid cells. Nature 406:519-524.
63. WuW, et al. 2011. Dynamics of the epigenetic landscape during erythroid differentiation after GATA1 restoration. Genome Res. 21:1659-1671.
64. Yu M, et al. 2009. Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis. Mol. Cell 36: 682-695.
65. Zhang J, Socolovsky M, Gross AW, Lodish HF. 2003. Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system. Blood 102:3938-3946.